Search results for "Reduced dose"

showing 4 items of 4 documents

Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the…

2022

Abstract Objectives To assess the toxicity patterns and effectiveness of doublet chemotherapy when administered at reduced doses of 20% (FOLFOX or FOLFIRI) in combination with anti-EGFR antibodies (cetuximab or panitumumab) in old, vulnerable patients with metastatic colorectal cancer (mCRC). Patients and methods We performed a retrospective observational study of RAS and BRAF wild-type, vulnerable patients aged ≥70 years with previously untreated mCRC. The primary endpoint was safety, and secondary endpoints were overall response rate (ORR), progression-free survival (PFS), and overall survival (OS). Results One hundred and eighteen patients were collected from 14 selected Italian centres.…

medicine.medical_specialtyReduced doseColorectal cancerLeucovorinCetuximabNeutropeniaGastroenterologyFOLFOXInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineClinical endpointHumansPanitumumabDoublet chemotherapyAnti-EGFRAgedCetuximabMetastatic colorectal cancerRectal Neoplasmsbusiness.industryPanitumumabAnti-EGFRs Doublet chemotherapy Metastatic colorectal cancer Reduced doses Vulnerable older patientsExanthemamedicine.diseaseRashVulnerable older patients.OncologyColonic NeoplasmsFOLFIRIFluorouracilGeriatrics and Gerontologymedicine.symptomColorectal Neoplasmsbusinessmedicine.drugJournal of Geriatric Oncology
researchProduct

Reduced-dose computed tomography is the most accurate method to measure ceramic hip resurfacing cup version

2020

Background: A precise assessment of cup version after hip resurfacing is generally requested, especially in clinical trials or in case of complications. Aims: To identify which diagnostic imaging modality, between AP pelvis X-rays, the AP Pelvis CT Scout image and reduced-dose axial CT scan, is the most precise to assess cup version of an all-ceramic hip resurfacing implant in a first-in-human clinical trial. Methods: We retrospectively assessed the cup version of the first 20 patients who underwent an experimental all-ceramic hip resurfacing on AP pelvis X-rays (0.8 mSv of radiation), AP pelvis CT scout images (0.016 mSv) and axial CT slices performed using a reduced dose protocol (0.3 mSv…

MaleCeramicsArthroplasty Replacement Hipmedicine.medical_treatmentReproducibility of ResultComputed tomographyCT scout viewRadiation DosageHip joint replacement030218 nuclear medicine & medical imaging03 medical and health sciencesCT/low dose0302 clinical medicineRetrospective StudieMedical imagingmedicineX-rays/radiographsHumansHip ProsthesiRadiology Nuclear Medicine and imagingPelvisRetrospective Studiesmedicine.diagnostic_testX-rays/radiographbusiness.industryReproducibility of ResultsGeneral MedicineMiddle AgedHip joint/cup versionCeramicReduced doseHip resurfacingHip joint/replacementRadiation exposureTomography x ray computedmedicine.anatomical_structure030220 oncology & carcinogenesisFemaleHip JointHip ProsthesisHip joint/resurfacingTomography X-Ray ComputedNuclear medicinebusinessHuman
researchProduct

Spacers and Valved Holding Chambers—The Risk of Switching to Different Chambers

2020

© 2020 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

corticosteroidSpacerinhalation spacerQ1lung03 medical and health sciences0302 clinical medicineDrug Delivery SystemsdysphoniaRC705InhalersAdministration InhalationImmunology and AllergyMedicineHumansmetered dose inhaler030212 general & internal medicineMetered Dose InhalershumanParticle Sizesnoutbusiness.industryInhaleradultthroat irritationInhalerarticleValved holding chamberrisk assessmentR735Equipment DesignReduced doseValved Holding ChambersMetered-dose inhalerthrushR1030228 respiratory systemDelivery systembusinessvalveBiomedical engineeringInhalation Spacers
researchProduct

P-42 Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies as treatment option in vulnerable older patients with metastatic colorec…

2021

Oncologymedicine.medical_specialtyChemotherapybiologybusiness.industryColorectal cancermedicine.medical_treatmentTreatment optionsRetrospective cohort studyHematologymedicine.diseaseReduced doseOncologyOlder patientsInternal medicinebiology.proteinMedicineAntibodybusinessAnnals of Oncology
researchProduct